Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Damish, A."'
Supplementary Table 2 from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
Autor:
Alan D. D'Andrea, Eliezer M. Van Allen, Jason L. Hornick, Harvey J. Mamon, Scott Carter, Gad Getz, Neil E. Martin, Charles S. Fuchs, Patrick A. Ott, Joanna Chin, Alexis Damish, Diana Miao, Ali Amin-Mansour, Jaegil Kim, Lior Z. Braunstein, Jonathan Pike, Brendan Reardon, James M. Cleary, Kent W. Mouw
Supplementary Table 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa4a564b5b2c5354054e0fe7a2d7350
https://doi.org/10.1158/1078-0432.22462857
https://doi.org/10.1158/1078-0432.22462857
Autor:
Kent W. Mouw, Gopa Iyer, Eliezer M. Van Allen, Nadeem Riaz, Alan D. D'Andrea, Jonathan E. Rosenberg, Dean Bajorin, David B. Solit, Jean-Bernard Lazaro, Elizabeth R. Plimack, Joaquim Bellmunt, Philip H. Abbosh, Jennifer Ma, S. Paul Gao, Emmet J. Jordan, Huiyong Zhao, Andrew Bell, Atanas Kamburov, Elizaveta Reznichenko, David Liu, Zoë Frazier, Alexis W. Damish, Qiang Li
Purpose:DNA-damaging agents comprise the backbone of systemic treatment for many tumor types; however, few reliable predictive biomarkers are available to guide use of these agents. In muscle-invasive bladder cancer (MIBC), cisplatin-based chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b9d3b09245d47c44f6976675089b967
https://doi.org/10.1158/1078-0432.c.6527114
https://doi.org/10.1158/1078-0432.c.6527114
Supplementary Table 3 from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
Autor:
Alan D. D'Andrea, Eliezer M. Van Allen, Jason L. Hornick, Harvey J. Mamon, Scott Carter, Gad Getz, Neil E. Martin, Charles S. Fuchs, Patrick A. Ott, Joanna Chin, Alexis Damish, Diana Miao, Ali Amin-Mansour, Jaegil Kim, Lior Z. Braunstein, Jonathan Pike, Brendan Reardon, James M. Cleary, Kent W. Mouw
Supplementary Table 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f08ff4876a5d771fd215e08f9fc4b92
https://doi.org/10.1158/1078-0432.22462854
https://doi.org/10.1158/1078-0432.22462854
Autor:
Kent W. Mouw, Gopa Iyer, Eliezer M. Van Allen, Nadeem Riaz, Alan D. D'Andrea, Jonathan E. Rosenberg, Dean Bajorin, David B. Solit, Jean-Bernard Lazaro, Elizabeth R. Plimack, Joaquim Bellmunt, Philip H. Abbosh, Jennifer Ma, S. Paul Gao, Emmet J. Jordan, Huiyong Zhao, Andrew Bell, Atanas Kamburov, Elizaveta Reznichenko, David Liu, Zoë Frazier, Alexis W. Damish, Qiang Li
Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f0d4147d71aa689dd1b9ee95bffc5d
https://doi.org/10.1158/1078-0432.22468982
https://doi.org/10.1158/1078-0432.22468982
Autor:
Kent W. Mouw, Gopa Iyer, Eliezer M. Van Allen, Nadeem Riaz, Alan D. D'Andrea, Jonathan E. Rosenberg, Dean Bajorin, David B. Solit, Jean-Bernard Lazaro, Elizabeth R. Plimack, Joaquim Bellmunt, Philip H. Abbosh, Jennifer Ma, S. Paul Gao, Emmet J. Jordan, Huiyong Zhao, Andrew Bell, Atanas Kamburov, Elizaveta Reznichenko, David Liu, Zoë Frazier, Alexis W. Damish, Qiang Li
Supplementary Figures and Methods // Supplementary Figure 1: The DDB2 proteo-probe assay measures cellular nucleotide excision repair (NER) capacity. Low magnification (20X) images of wild-type (WT) or mutant ERCC2-complemented XP cells before, 5 min
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18879e716b0b4951d34e6939bb98b8e7
https://doi.org/10.1158/1078-0432.22468985.v1
https://doi.org/10.1158/1078-0432.22468985.v1
Autor:
Alan D. D'Andrea, Eliezer M. Van Allen, Jason L. Hornick, Harvey J. Mamon, Scott Carter, Gad Getz, Neil E. Martin, Charles S. Fuchs, Patrick A. Ott, Joanna Chin, Alexis Damish, Diana Miao, Ali Amin-Mansour, Jaegil Kim, Lior Z. Braunstein, Jonathan Pike, Brendan Reardon, James M. Cleary, Kent W. Mouw
Supplementary Methods, Tables, and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3846683e7ccaf40e6689355161a4c545
https://doi.org/10.1158/1078-0432.22462860
https://doi.org/10.1158/1078-0432.22462860
Autor:
Alan D. D'Andrea, Eliezer M. Van Allen, Jason L. Hornick, Harvey J. Mamon, Scott Carter, Gad Getz, Neil E. Martin, Charles S. Fuchs, Patrick A. Ott, Joanna Chin, Alexis Damish, Diana Miao, Ali Amin-Mansour, Jaegil Kim, Lior Z. Braunstein, Jonathan Pike, Brendan Reardon, James M. Cleary, Kent W. Mouw
Purpose: Squamous cell carcinoma of the anal canal (ASCC) accounts for 2% to 4% of gastrointestinal malignancies in the United States and is increasing in incidence; however, genomic features of ASCC are incompletely characterized. Primary treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be3a397648f1415d9d1a6beb255961f
https://doi.org/10.1158/1078-0432.c.6525234.v1
https://doi.org/10.1158/1078-0432.c.6525234.v1
Autor:
Hasindu Dahanayake, Damish Samarajeewa, Arosha Jayathilake, Dinithi Bandara, Anuradha Karunasena, Lokesha Weerasinghe
Publikováno v:
2021 IEEE 12th Annual Ubiquitous Computing, Electronics & Mobile Communication Conference (UEMCON).
Autor:
S. Paul Gao, Nadeem Riaz, Elizabeth R. Plimack, Qiang Li, Atanas Kamburov, Gopa Iyer, Andrew C. Bell, David Liu, Jean-Bernard Lazaro, Jonathan E. Rosenberg, Joaquim Bellmunt, Emmet Jordan, Alexis W. Damish, Zoë Frazier, Elizaveta Reznichenko, Kent W. Mouw, Eliezer M. Van Allen, Huiyong Zhao, Philip Abbosh, Jennifer Ma, David B. Solit, Dean F. Bajorin, Alan D. D'Andrea
Publikováno v:
Clinical Cancer Research. 25:977-988
Purpose: DNA-damaging agents comprise the backbone of systemic treatment for many tumor types; however, few reliable predictive biomarkers are available to guide use of these agents. In muscle-invasive bladder cancer (MIBC), cisplatin-based chemother
Autor:
Salam, Farhan1, Arslan, Damish2, Qureshi, Muhammad Salman Haider3 pmc.salmanqureshi@gmail.com, Ahmad, Ejaz4
Publikováno v:
Professional Medical Journal. 2018, Vol. 25 Issue 8, p1213-1217. 5p.